program details

This CME program covers late breaking clinical trials, hot topics in cardiology, and unique disease management discussions.

This program provides expert coverage of late breaking trial news and balanced clinical information covered on the behalf of ClinicalTrialResults.org. A variety of current topics in cardiology and disease management were captured during the November 2007 AHA annual meeting held in Orlando, Florida.

Release date: 5/5/08
Expiration date: 5/5/09

PURPOSE STATEMENT
The purpose of this activity is to assist cardiologists in improving patient outcomes by providing insights from national quality improvement initiative, as well as reviewing results from recent and late-breaking clinical trials of treatments in patients with acute coronary syndromes

TARGET AUDIENCE
Cardiology Physicians

• Analyze the efficacy of antiplatelet therapies used in the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet InhibitioN with Prasugrel. ^1,2
  
  
• Define the role of the eptifibatide in treating patients undergoing percutaneous coronary intervention. ^3,4,5,6
  
  
• Discuss how the adverse side effects of warfarin for patients with atrial fibrillation (AF) have driven recent studies. ^7,8
  
  
• Identify the level of awareness and adherence to ACC/AHA Acute Coronary Syndromes (ACS) guidelines found in the CRUSADE study. ^9,10,11
  
  
• Discuss the results of decompensated heart failure (ADHF) clinical trials. ^12,13,14
  
  
• Identify the effectiveness of anticoagulants that target Factor Xa versus anticoagulants that inhibit Factor IIa. ^15,16,17

CONTENT SUPPORT REFERENCES
Click here.

FACULTY
C. Michael Gibson, MS, MD
Anthony Fung, MD
Kenneth W. Mahaffey, MD
Matthew T. Roe, MD, MHS, FACC
A.G.G. Turpie, MD, FRCP, FRCPC
Clyde W. Yancy, MD, FACC, FAHA, FACP

ACCME
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of Medical Education Collaborative, Inc. (MEC) and Center for Healthcare Education.  The Medical Education Collaborative is accredited by the ACCME to provide continuing medical education for physicians.

Medical Education Collaborative designates this educational activity for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

For questions regarding the accreditation of this activity, please contact Medical Education Collaborative at (303) 420-3252 or inquire@meccme.org.

INSTRUCTIONS FOR RECEIVING CME CREDIT
Viewers are expected to visit all presentations before attempting to take the test and activity evaluation. Successful completion will lead to the issuance of a certificate for 1.5 AMA PRA Category 1 Credit(s) ™. To receive credit, the course must be completed before May 5, 2009.

Participation in this activity should be completed in approximately 1.5 hours. Please follow these steps in order to receive CME credit for viewing the webcast:

• Read the target audience, objectives, faculty disclosures, accreditation statements and commercial supporter(s).

• Complete the online registration (registration is free).

• After listening to all the presentations, print out the post-test, evaluation form, and credit application.

• Complete the post-test, and mail or fax the post-test, evaluation form, and credit application to the address listed below.

• Participants must receive a test score of at least 75% and submit a completed evaluation form and credit application to receive a certificate by the CME provider.

• Please allow 3-4 weeks to receive a certificate.

NOTE: Participants who attended the live activity held on November 3-7, 2007 in Orlando, FL are not eligible to receive credit for this online activity.

Medical Education Collaborative 651 Corporate Circle, Suite #104 Golden, CO 80401 866.420.3252 Fax: 303.420.3259

DISCLOSURE
Medical Education Collaborative adheres to ACCME and ANCC Essential Areas and Policies, including the Standards for Commercial Support regarding industry support of continuing medical education. In order to resolve any identified conflicts of interest, disclosure information is provided during the planning process to ensure resolution of any identified conflicts. Disclosure of faculty and commercial relationships, as well as the discussion of unlabeled or unapproved use of any drug, device, or procedure by the faculty, are made known below.

Employees of Medical Education Collaborative, the accredited provider for this activity, or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interests related to the content of this CME activity for any amount during the past 12 months.

Employees of The Center for Healthcare Education,  the joint sponsor for this activity, or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interests related to the content of this CME activity for any amount during the past 12 months.

SPONSOR INFORMATION
This activity is jointly-sponsored by Medical Education Collaborative and Center for Healthcare Education.

COMMERCIAL SUPPORT INFORMATION
This activity is supported by educational grants from Daiichi Sankyo Lilly, Genentech, Pfizer, Scios and Schering-Plough.

LEGAL DISCLAIMER
The opinions expressed in this educational activity are those of the faculty and do not reflect the views of Medical Education Collaborative and Center for Healthcare Education. This educational activity may discuss off-label and/or investigational uses and dosages for therapeutic products/procedures that have not been approved by the United States Food and Drug Administration (FDA). Medical Education Collaborative and Center for Healthcare Education do not recommend the use of any product/procedure outside of the labeled indications. A qualified health care professional should be consulted before using any therapeutic product/procedure discussed. All readers and continuing education participants should verify all information and data before treating patients or employing any therapies described in this continuing education activity.  Please refer to the official prescribing information for each product/procedures for approved indication, contraindications, and warnings.

POLICY ON PRIVACY AND CONFIDENTIALITY
Medical Education Collaborative (MEC) protects the privacy of personal and other information regarding participants, educational partners, and joint sponsors. MEC and our joint sponsors will not release personally identifiable information to a third party without the individual’s consent, except such information as is required for reporting purposes to the appropriate accrediting agency.

Medical Education Collaborative (MEC) and Center for Healthcare Education maintain physical, electronic and procedural safeguards that comply with federal regulations to guard your nonpublic personal information.

HARDWARE AND SOFTWARE REQUIREMENTS
The Center for Healthcare Education recommends Internet Explorer 6.0 or later, or Firefox 2.0 or later, Adobe Acrobat Reader and Adobe Flash Player 6.0 or later. Certain educational activities may require additional software. These activities will be marked as such, and will provide links to the required software.

This activity has been made available online.

Copyright © May 5, 2008 – May 5, 2009 Center for Healthcare Education. All Rights Reserved. Permission for accreditation use granted to Medical Education Collaborative (MEC).